At Garvan, we see a future where everyone lives a longer, healthier life.
By being a global leader in discovery research and driving the translation of breakthroughs from the lab to the clinic, we can revolutionise human health using the power of genomic information.
We will harness all the information encoded in our genome to better diagnose, treat and prevent diseases that have the deepest impact on society.
Garvan brings together world-leading researchers and clinicians, collaborating locally and globally, to improve human health. For the individual patient with rare disease, to the many thousands affected by complex, widespread illness, we are pioneering discoveries across diseases that have the deepest impact on our community.
Through our key scientific strengths in data, genomics, cellular, translational and clinical science, and enabled by cutting-edge technology and world-class facilities, we aim to catalyse research from fundamental discovery to transformational impact.
We seek impact in four key areas
- Clinical impact: provide better diagnosis, prevention and treatment of disease
- Scientific impact: advance scientific knowledge, understanding and technology to support clinical impact
- Economic impact: create cost savings for society through improved health and effective treatments, and business creation to increase community access to breakthrough therapies
- Social impact: contribute to the welfare and wellbeing of the community as a whole.